We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCY icon
2676
Mercury Insurance
MCY
$5.84B
$89K ﹤0.01%
1,455
-2,232
-61% -$128K
RLX icon
2677
RLX Technology
RLX
$2.44B
$89K ﹤0.01%
+8,564
New +$165K
TAC icon
2678
TransAlta
TAC
$3.92B
$89K ﹤0.01%
9,423
+5,791
+159% +$51.3K
TELL
2679
DELISTED
Tellurian Inc.
TELL
$89K ﹤0.01%
37,921
+27,244
+255% +$74.3K
ARAV
2680
DELISTED
Aravive, Inc. Common Stock
ARAV
$89K ﹤0.01%
13,470
+9,412
+232% +$61.9K
CLW icon
2681
Clearwater Paper
CLW
$356M
$88K ﹤0.01%
2,343
-4,772
-67% -$190K
CTMX icon
2682
CytomX Therapeutics
CTMX
$760M
$88K ﹤0.01%
11,361
+7,537
+197% +$59.7K
GLDD
2683
DELISTED
Great Lakes Dredge & Dock
GLDD
$88K ﹤0.01%
6,041
+4,063
+205% +$59.2K
PDFS icon
2684
PDF Solutions
PDFS
$2.19B
$88K ﹤0.01%
4,981
+3,859
+344% +$76.5K
URGN icon
2685
UroGen Pharma
URGN
$2.39B
$88K ﹤0.01%
4,550
-1,138
-20% -$24.2K
WANT icon
2686
Direxion Daily Consumer Discretionary Bull 3X ETF
WANT
$21.5M
$88K ﹤0.01%
1,566
-978
-38% -$54.2K
WPM icon
2687
Wheaton Precious Metals
WPM
$61.3B
$88K ﹤0.01%
2,294
-29,654
-93% -$1.18M
KRA
2688
DELISTED
Kraton Corporation
KRA
$88K ﹤0.01%
2,406
-4,033
-63% -$144K
HAFC icon
2689
Hanmi Financial
HAFC
$956M
$87K ﹤0.01%
4,410
+2,401
+120% +$38.9K
KELYA icon
2690
Kelly Services Class A
KELYA
$536M
$87K ﹤0.01%
3,899
+2,122
+119% +$45.1K
KRYS icon
2691
Krystal Biotech
KRYS
$9.85B
$87K ﹤0.01%
1,118
+474
+74% +$34.5K
SKF icon
2692
ProShares UltraShort Financials
SKF
$10.4M
$87K ﹤0.01%
892
-1,303
-59% -$145K
SLP icon
2693
Simulations Plus
SLP
$371M
$87K ﹤0.01%
1,366
+1,114
+442% +$81.7K
DCOY
2694
Decoy Therapeutics
DCOY
$1.92M
$87K ﹤0.01%
+2
New +$115K
WEBS icon
2695
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$6.79M
$87K ﹤0.01%
+381
New +$89.5K
DMTK
2696
DELISTED
DermTech, Inc. Common Stock
DMTK
$87K ﹤0.01%
1,717
+19
+1% +$994
RUBY
2697
DELISTED
Rubius Therapeutics, Inc
RUBY
$87K ﹤0.01%
3,302
-541
-14% -$7.9K
DRNA
2698
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$87K ﹤0.01%
3,414
-4,991
-59% -$127K
AZEK
2699
DELISTED
The AZEK Co
AZEK
$86K ﹤0.01%
2,052
+715
+53% +$30.6K
BYND icon
2700
Beyond Meat
BYND
$214M
$86K ﹤0.01%
22
-54
-71% -$238K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.